Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002783 · ClinicalTrials.gov registry record · Phase 2

Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer

A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 2
Development phase
50
Enrollment target

NCT00002783: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00002783 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00002783, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
50 participants
Enrollment target

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surgery in treating patients with high-risk stomach cancer.

Interventions

  • DRUG cisplatin
  • DRUG fluorouracil
  • DRUG leucovorin calcium
  • PROCEDURE conventional surgery
  • DRUG floxuridine

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 1996-05
Est. Completion 2001-01
Phase Phase 2
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00002783 record still lists

NCT00002783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.

NCT00002783 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00002783 about?

NCT00002783 is a clinical study titled "Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surge...

What is the current status of trial NCT00002783?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1996-05. Estimated completion is 2001-01.

What interventions are being tested in trial NCT00002783?

The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), leucovorin calcium (DRUG), conventional surgery (PROCEDURE), floxuridine (DRUG).

Who is sponsoring clinical trial NCT00002783?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00002783's enrollment target sits among peer trials

50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00002783, the US trial registry maintained by the National Library of Medicine. NCT00002783 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.